Clinical trial
Influence of Amlodipine on the Mortality of Patients With End-Stage Renal…
NCT00124969 · Charite University, Berlin, Germany, Other · Completed
Key facts
| NCT number | NCT00124969 |
|---|---|
| Title | Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure |
| Official title | Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality]) |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Amlodipine, Placebo |
| Enrollment | 356 |
| Start date | Jan 1, 2002 |
| Completion | Oct 1, 2006 |
| First posted | Jul 29, 2005 |
| Last update posted | May 9, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: